COVID-19 and Rhino-orbital Mucormycosis

Clinical Profile and Outcome of Post Covid-19 Rhino-orbital Fungal Mucormycosis in Minia Governorate

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05212961

Enrollment

Registered

2022-01-28

Start date

2021-12-28

Completion date

2023-09-28

Last updated

2023-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucormycosis

Brief summary

Detect the clinical presentation and outcome of post covid-19 fungal mucormycosis in patients referred to Minia university Hospital.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

1. Patients who had positive PCR test for Covid-19. 2. Fungal rhino-orbital infection was confirmed.

Exclusion criteria

1. Suspected patient with COVID-19 not confirmed with PCR 2. Incomplete data

Design outcomes

Primary

Measure	Time frame	Description
Outcome of rhino-orbital mucormycosis in COVID-19 patients	9 months	Data of the patients who had post Covid-19 fungal mucormycosis in the last year will be revised to detect clinical presentation and final outcome

Countries

Egypt

Outcome results